Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

DB Alex Brown Boosts Guidant to 'Strong Buy'

DB Alex Brown upgraded Guidant Corp. (GDT) to strong buy from buy.

Analyst Sheryl Zimmer says the agreement gives Guidant the ability to sell a paclitaxel coated Penta stent. She sees this ingenious (though unusual) agreement as an important positive as it meaningfully accelerates Guidant's drug-coated stent development -- putting them only six months behind Johnson & Johnson.

Zimmer says this news, coupled with recent positive developments for its Ancure AAA stent graft, indicates Guidant may finally be getting themselves back on a growth trajectory. She has a $42 target.

blog comments powered by Disqus